Merck (MRK) Total Debt (2009 - 2026)

Merck (MRK) has reported Total Debt for 18 consecutive years, with $53.9 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Debt rose 52.27% year-over-year to $53.9 billion in Q2 2026; TTM through Jun 2026 was $53.9 billion, a 52.27% increase from a year earlier, with the FY2025 full-year figure at $49.3 billion, up 32.95% from the prior year.
• Total Debt was $53.9 billion for Q2 2026 at Merck, up from $49.1 billion in the prior quarter.
• Over five years, Total Debt peaked at $53.9 billion in Q2 2026 and troughed at $30.4 billion in Q3 2022.
• A 5-year average of $37.4 billion and a median of $35.2 billion in 2023 frame the typical range for Total Debt.
• Across the five-year window, Total Debt fell 7.28% in 2022 and surged 52.27% in 2026, its largest moves.
• Over 5 years, Total Debt stood at $30.7 billion in 2022, then advanced by 14.22% to $35.1 billion in 2023, then grew by 5.87% to $37.1 billion in 2024, then surged by 32.95% to $49.3 billion in 2025, then grew by 9.26% to $53.9 billion in 2026.
• The last three Total Debt figures came in at $53.9 billion (Q2 2026), $49.1 billion (Q1 2026), and $49.3 billion (Q4 2025), per Business Quant data.